Mentors Offering Maternal Support (M-O-M-S)
Behavioral10, 1 hour, structured classes meeting every-other-week in person beginning in the first trimester of pregnancy and unlimited access to mentor support.
NCT Number: NCT03393637
The M-O-M-S project evaluates the effectiveness of the M-O-M-S program for improving birth outcomes and maternal-infant attachment and role satisfaction in a large military sample.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Naval Medical Center San Diego, San Diego, California, United States
The M-O-M-S project is a longitudinal, multi-site, randomized controlled trial to test program effectiveness for decreasing prenatal maternal anxiety and depression and increasing self-esteem and resilience and assess the relationship to pregnancy complications, birth outcomes, postpartum maternal-infant attachment, role satisfaction and parental stress.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
10, 1 hour, structured classes meeting every-other-week in person beginning in the first trimester of pregnancy and unlimited access to mentor support.
Time frame: assessing change between gestational weeks 12, 16, 24, and 32 of pregnancy
Seven dimensions of pregnancy-specific anxiety
Time frame: assessing change between gestational weeks 12, 16, 24, and 32 of pregnancy and 1, 3, & 6 months postpartum
10-item scale measuring the degree to which one values oneself
Time frame: assessing change between gestational weeks 12, 16, 24, and 32 of pregnancy and 1, 3, & 6 months postpartum
30-item instrument measuring the ability of the family (couple) to change its roles, rules, and power structure.
Time frame: assessing change between gestational weeks 12, 16, 24, and 32 of pregnancy and 1, 3, & 6 months postpartum
10-item scale measuring prenatal or postpartum symptoms of depression
Time frame: assessing change between gestational weeks 12, 16, 24, and 32 of pregnancy and 1, 3, & 6 months postpartum
17-item scale measuring the extent to which families are integrated into the community, view the community as a source of support, and feel that the community can provide emotional, esteem, and network support
Time frame: assessing change between gestational weeks 12, 16, 24, and 32 of pregnancy and 1, 3, & 6 months postpartum
17-item instrument measuring the degree to which families feel committed to the military mission and identify a subscale of family coping to manage life changes and stresses
Time frame: assessing change between gestational weeks 12, 16, 24, and 32 of pregnancy and 1, 3, & 6 months postpartum
6-item instrument developed to measure the concept of "bouncing back from stress."
Time frame: assessing change between 1, 3, & 6 months postpartum
82-items measuring the woman's perceived postpartum adaptation to motherhood
Time frame: delivery weight of infant documented at delivery
exact measure obtained from the delivery or infant record of the infants weight at birth in grams
Time frame: at first prenatal appointment up to 12 weeks
Gestational age in weeks at birth determined from last menstrual period (LMP) and/or first trimester ultrasound
University of the Incarnate Word
Other
Mentors Offering Maternal Support (M-O-M-S™): A Prenatal Program Building Maternal Self-Esteem, Coping, and Resilience and Decreasing Depression.
Acronym: M-O-M-S
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03797716
Alzheimer Disease, Anxiety Acute
Barnet, United Kingdom
View Trial DetailsNCT03690531
Anxiety Fear, Neurologic Manifestations
Brooklyn, New York, United States
View Trial DetailsNCT05756634
Behavior, Behavioral Symptoms
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT03880032
Anxiety, Anxiety Disorders
Rawalpindi, Pakistan
View Trial Details